Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-11-16 5:39 pm Sale | 2026-09-30 | 13G | CRESCENT BIOPHARMA, INC CBIO | Venrock Healthcare Capital Partners III, L.P. | 2,228,641 5.900% | -437,423![]() (-16.41%) | Filing History |
| 2026-11-16 4:09 pm Purchase | 2026-09-30 | 13G | CRESCENT BIOPHARMA, INC CBIO | BIOTECHNOLOGY VALUE FUND L P | 3,691,518 9.800% | 2,303,655![]() (+165.99%) | Filing History |
| 2026-11-16 06:00 am Sale | 2026-09-30 | 13G | CRESCENT BIOPHARMA, INC CBIO | Balyasny Asset Management L.P. | 1,611,958 4.340% | -50,959![]() (-3.06%) | Filing History |
| 2026-10-27 5:25 pm Purchase | 2026-09-30 | 13G | CRESCENT BIOPHARMA, INC CBIO | BlackRock Inc. BLK | 2,075,291 5.600% | 2,066,430![]() (+23320.51%) | Filing History |
| 2026-08-14 06:01 am Purchase | 2026-06-30 | 13G | CRESCENT BIOPHARMA, INC CBIO | Balyasny Asset Management L.P. | 1,662,917 6.030% | 152,884![]() (+10.12%) | Filing History |
| 2026-07-20 5:30 pm Purchase | 2026-07-16 | 13D | CRESCENT BIOPHARMA, INC CBIO | Fairmount Funds Management LLC | 6,602,408 16.520% | 958,926![]() (+16.99%) | Filing History |
| 2026-05-15 4:15 pm Purchase | 2026-03-31 | 13G | CRESCENT BIOPHARMA, INC CBIO | TANG CAPITAL MANAGEMENT, LLC | 1,160,000 4.210% | 460,000![]() (+65.71%) | Filing History |
| 2026-05-15 06:31 am Purchase | 2026-03-31 | 13G | CRESCENT BIOPHARMA, INC CBIO | Balyasny Asset Management L.P. | 1,510,033 5.480% | 1,510,033![]() (New Position) | Filing History |
| 2026-02-17 6:05 pm Purchase | 2025-12-31 | 13G | CRESCENT BIOPHARMA, INC CBIO | Venrock Healthcare Capital Partners III, L.P. | 2,666,064 9.500% | 1,274,868![]() (+91.64%) | Filing History |
| 2026-02-17 4:06 pm Purchase | 2025-12-31 | 13G | CRESCENT BIOPHARMA, INC CBIO | Vestal Point Capital, LP | 1,500,000 5.400% | 1,500,000![]() (New Position) | Filing History |
| 2026-02-05 1:20 pm Purchase | 2025-12-31 | 13G | CRESCENT BIOPHARMA, INC CBIO | FMR LLC | 4,133,514 15.000% | 2,719,324![]() (+192.29%) | Filing History |
| 2025-12-11 4:00 pm Purchase | 2025-12-08 | 13G | CRESCENT BIOPHARMA, INC CBIO | ForGrowth III PA B.V. | 1,677,852 6.100% | 1,677,852![]() (New Position) | Filing History |
| 2025-12-08 4:30 pm Purchase | 2025-12-04 | 13D | CRESCENT BIOPHARMA, INC CBIO | Fairmount Funds Management LLC | 5,643,482 18.530% | 2,519,262![]() (+80.64%) | Filing History |
| 2025-10-14 3:41 pm Purchase | 2025-10-07 | 13G | CRESCENT BIOPHARMA, INC CBIO | 1Globe Capital LLC | 1,425,432 10.300% | 528,720![]() (+58.96%) | Filing History |
| 2025-10-09 4:15 pm Purchase | 2025-10-02 | 13G | CRESCENT BIOPHARMA, INC CBIO | TANG CAPITAL MANAGEMENT, LLC | 700,000 5.040% | 700,000![]() (New Position) | Filing History |
| 2025-08-20 5:20 pm Purchase | 2025-08-13 | 13G | CRESCENT BIOPHARMA, INC CBIO | 1Globe Capital LLC | 896,712 6.450% | 896,712![]() (New Position) | Filing History |
| 2025-08-14 4:01 pm Purchase | 2025-06-30 | 13G | CRESCENT BIOPHARMA, INC CBIO | BIOTECHNOLOGY VALUE FUND L P | 1,387,863 9.990% | 1,292,420![]() (+1354.13%) | Filing History |
| 2025-08-14 2:24 pm Purchase | 2025-06-30 | 13G | CRESCENT BIOPHARMA, INC CBIO | Logos Global Management LP | 575,000 4.100% | 525,000![]() (+1050.00%) | Filing History |
| 2025-07-08 09:07 am Purchase | 2025-06-30 | 13G | CRESCENT BIOPHARMA, INC CBIO | FMR LLC | 1,414,190 10.200% | 1,396,091![]() (+7713.64%) | Filing History |
| 2025-06-23 6:32 pm Purchase | 2025-06-13 | 13D | CRESCENT BIOPHARMA, INC CBIO | Fairmount Funds Management LLC | 3,124,220 19.990% | 3,124,220![]() (New Position) | Filing History |

